Chronic daily headache: Nosology and pathophysiology

Current Opinion in Neurology

Volumn 15, Issue 3, 2002, Pages 287-295

  Welch, K Michael A ^a   Goadsby, Peter J ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CALCITONIN GENE RELATED PEPTIDE DERIVATIVE; MORPHINE; OPIATE AGONIST;

ADULT; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG USE; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SUBARACHNOID HEMORRHAGE; TENSION HEADACHE;

BRAIN; CALCITONIN GENE-RELATED PEPTIDE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; MUSCLE, SKELETAL; NEURAL PATHWAYS;

EID: 0036263758     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200206000-00011     Document Type: Review

References (63)

1. Headache as a metonymy of non-organic central pain
2. Transformation of migraine into daily headache: Analysis of factors
3. The natural history and epidemiology of migraine and muscle contraction headache
4. A personal view of the classification and definition of drug dependence headache
5. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
6. Prevalence of frequent headache in a population sample
7. Epidemiology of chronic daily headache in the general population
8. Chronic daily headache in Chinese elderly. Prevalence, risk factors and biannual follow-up
9. Revision of the International Headache Classification. An interim report
10. Evaluation of chronic daily headache: Comparison to criteria for chronic tension-type headache
11. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
12. Sumatriptan for the range of headaches in migraine sufferers: Results of the Spectrum Study
13. Evaluation of nosology of chronic tension-type headache
14. Classification of daily or near-daily headaches: Proposed revisions to the IHS criteria
15. Classification of chronic daily headache by International Headache Society criteria: Limits and new proposals
16. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches
17. New daily persistent headaches: Definition of a benign syndrome
18. Chronic daily headache
19. Hemicrania continua: Another headache absolutely responsive to indomethacin
20. Classification of daily and near-daily headaches: A field study of revised IHS criteria
21. Does analgesic abuse cause headaches de novo
22. Does chronic daily headache arise de novo in association with regular analgesic use?
23. Paradoxical effects of frequent analgesic use
24. Comparison of first degree relatives and spouses of people with chronic tension-type headache
25. Initiating mechanisms of experimentally induced tension-type headache
26. Comparative study with EMG, pressure algometry and manual palpation in tension-type headache and migraine
27. Pericranial muscle hardness in tension-type headache: A non-invasive measurement method and its clinical application
28. Sensitization of myofacial pain pathways in tension-type headache
29. Exteroceptive supression of temporalis muscle activity in chronic headache
30. Exteroceptive suppression periods and pericranial muscle tenderness in chronic tension-type headache: Effects of psychopathology, chronicity and disability
31. Derangement of serotonin system in migrainous patients with analgesic abuse headache
32. Platelet serotonin in patients with analgesic-induced headache
33. Alteration of central excitation circuits in chronic headache and analgesic misuse
34. Modulation of excitatory amino acid pathways: A possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse
35. Serum beta-endorphin increase after intravenous histamine
36. Hypothesis: Chronic benign daily headache is an immune disorder with a viral trigger
37. Cellular adaptation in migraineurs with chronic daily headache
38. Natural history of cluster headache
39. Cluster headache: Course over ten years in 189 patients
40. A follow up study of 60 patients after an assumed first period of cluster headache
41. Analgesic-induced chronic daily headache: Long-term results of withdrawal therapy
42. Periaqueductal grey matter dysfunction in migraine: Cause or the burden of illness?
43. MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine
44. Central nervous system mechanisms of pain modulation
45. Headache may arise from perturbation of brain
46. Headache secondary to deep brain implantation
47. Brain stem activation in spontaneous human migraine attacks
48. Animal models of headache
49. Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation
50. The periaqueductal gray matter modulates trigeminovascular input: A role in migraine?
51. On the functional anatomy of migraine
52. P/Q-type calcium channel blockade in the PAG facilitates trigeminal nociception: A functional genetic link for migraine?
53. Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal
54. 3H]-dihydroergotamine binding sites in the cat central nervous system: Relevance to migraine
55. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
56. Vasoactive peptides levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally
57. Human calcitonin gene-related peptide (hCGRP)-induced headache in migraineurs
58. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside attacks
59. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache
60. Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists
61. Pharmacological profile of BIBN-4096BS, the first selective small molecule CGRP antagonist